Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: A prospective, randomized trial

Blood

Volumn 89, Issue 10, 1997, Pages 3880-3887

  Deeg, H Joachim ^a   Lin, Danyu ^b   Leisenring, Wendy ^b   Boeckh, Michael ^b   Anasetti, Claudio ^b   Appelbaum, Frederick R ^b   Chauncey, Thomas R ^b   Doney, Kristine ^b   Flowers, Mary ^b   Martin, Paul ^b   Nash, Richard ^b   Schoch, Gary ^b   Sullivan, Keith M ^b   Witherspoon, Robert P ^b   Storb, Rainer ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; METHOTREXATE; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; WHOLE BODY RADIATION;

EID: 0030914537     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.10.3880.3880_3880_3887     Document Type: Article

References (40)

1. Deeg HJ, Storb R, Thomas ED, Flournoy N, Kennedy MS, Banaji M, Appelbaum FR, Bensinger WI, Buckner CD, Clift RA, Doney K, Fefer A, McGuffin R, Sanders JE, Singer J, Stewart P, Sullivan KM, Witherspoon RP: Cyclosporine as prophylaxis for graft-versus-host disease: A randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. Blood 65:1325, 1985
2. Storb R, Deeg HJ, Thomas ED, Appelbaum FR, Buckner CD, Cheever MA, Clift RA, Doney KC, Flournoy N, Kennedy MS, Loughran TP, McGuffin RW, Sale GE, Sanders JE, Singer JW, Stewart PS, Sullivan KM, Witherspoon RP: Marrow transplantation for chronic myelocytic leukemia: A controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease. Blood 66:698, 1985
3. Deeg HJ: Chemoprevention of graft-vs-host disease: Effects on donor marrow and host environment, in Gale RP, Champlin RE (eds): Bone Marrow Transplantation: Current Controversies. New York, NY, Liss, 1989, p 441
4. Deeg HJ, Storb R, Weiden PL, Raff RF, Sale GE, Atkinson K, Graham TC, Thomas ED: Cyclosporin A and methotrexate in canine marrow transplantation: Engraftment, graft-versus-host disease, and induction of tolerance. Transplantation 34:30, 1982
5. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum L, Martin P, McGuffin R, Sanders J, Stewart P, Sullivan K, Witherspoon R, Yee G, Thomas ED: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314:729, 1986
6. Ringden O, Klaesson S, Sundberg B, Ljungman P, Lonnqvist B, Persson U: Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings. Bone Marrow Transplant 9:19, 1992
7. Butturini A, Bortin MM, Gale RP: Graft-versus-leukemia following bone marrow transplantation. Bone Marrow Transplant 2:233, 1987
8. Forman SJ, Blume KG, Krance RA, Miner PJ, Metter GE, Hill LR, O'Donnell MR, Nademanee AP, Snyder DS: A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: Methotrexate/prednisone v cyclosporine A/prednisone. Transplant Proc 19:2605, 1987
9. Santos GW, Tutschka PJ, Brookmeyer R, Saral R, Beschorner WE, Bias WB, Braine HG, Burns WH, Farmer ER, Hess AD, Kaizer H, Mellits D, Sensenbrenner LL, Stuart R, Yeager AM: Cyclosporine plus methylprednisolone versus cyclophosphamide plus methylprednisolone as prophylaxis for graft-versus-host disease: A randomized double-blind study in patients undergoing allogeneic marrow transplantation. Clin Transplant 1:21, 1987
10. Sayer HG, Longton G, Bowden R, Pepe M, Storb R: Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention. Blood 84:1328, 1994
11. Verfaillie C, Weisdorf D, Haake R, Hosteller M, Ramsay NKC, McGlave P: Candida infections in bone marrow transplant recipients. Bone Marrow Transplant 8:177, 1991
12. Storb R, Pepe M, Anasetti C, Appelbaum FR, Beatty P, Doney K, Martin P, Stewart P, Sullivan KM, Witherspoon R, Bensinger W, Buckner CD, Clift R, Hansen J, Longton G, Loughran T, Petersen FB, Singer J, Sanders J, Thomas ED: What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants? Blood 76:1037, 1990
13. Ringdén O, Persson U, Gunnar S, Johansson O, Gahrton G, Groth C-G, Lundgren G, Lönnqvist B: Early diagnosis and treatment of acute human graft-versus-host disease. Transplant Proc 15:1490, 1983
14. Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C, Appelbaum FR, Bowden RA, Deeg HJ, Doney K, Martin PJ, Sullivan KM, Sanders J, Witherspoon RP: Acute graft-versus-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 80:1838, 1992
15. Tutschka PJ, Copelan EA, Klein JP: Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 70:1382, 1987
16. Deeg HJ, Cottier-Fox M: Clinical spectrum and pathophysiology of acute graft-vs.-host disease, in Burakoff SJ, Deeg HJ, Ferrara J, Atkinson K (eds): Graft-vs.-Host Disease: Immunology, Pathophysiology, and Treatment. New York, NY, Marcel Dekker, 1990, p 311
17. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone-marrow transplantation. N Engl J Med 292:832, 1975
18. Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR, Beatty PG, Doney K, McDonald GB, Sanders JE, Sullivan KM, Storb R, Thomas ED, Witherspoon RP, Lomen P, Hannigan J, Hansen JA: A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment. Blood 76:1464, 1990
19. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED: 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 15:825, 1995
20. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, Schubert MM, Atkinson K, Thomas ED: Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 57:267, 1981
21. Loughran TP Jr, Sullivan K, Morton T, Beckham C, Schubert M, Witherspoon R, Sale G, Sanders J, Fisher L, Shulman H, Thomas ED, Storb R: Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Blood 76:228, 1990
22. Bowden RA, Cays M, Gooley T, Mamelok R, van Burik J: Phase I study of amphotericin B colloidal dispersion (ABCD) for the treatment of invasive fungal infections after marrow transplant. J Infect Dis 173:1208, 1996
23. Pepe MS, Anderson GL: Two-stage experimental designs: Early stopping with a negative result. Appl Stat 41:181, 1992
24. Andersen PK, Gill RD: Cox's regression model for counting processes: A large sample study. Ann Stat 10:1100, 1982
25. Pepe MS, Longton G, Pettinger M, Mori M, Fisher LD, Storb R: Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: Motivation for and description of new methods. Br J Haematol 83:602, 1993
26. Pepe MS, Mori M: Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12:737, 1993
27. Hings IM, Filipovich AH, Miller WJ, Blazar BL, McGlave PB, Ramsay NK, Kersey JH, Weisdorf DJ: Prednisone therapy for acute graft-versus-host disease: Short-versus long-term treatment. A prospective randomized trial. Transplantation 56:577, 1993
28. Bacigalupo A, Van Lint MT, Frassoni F, Podesta M, Veneziano G, Avanzi G, Vitale V, Marmont AM: High dose bolus methyl-prednisolone for the treatment of acute graft versus host disease. Blut 46:125, 1983
29. Sullivan KM, Witherspoon RP, Storb R, Deeg HJ, Dahlberg S, Sanders JE, Appelbaum FR, Doney KC, Weiden P, Anasetti C, Loughran TP, Hill R, Shields A, Yee G, Shulman H, Nims J, Strom S, Thomas ED: Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-versus-host disease. Blood 72:555, 1988
30. Kennedy MS, Deeg HJ, Storb R, Doney K, Sullivan KM, Witherspoon RP, Appelbaum FR, Stewart P, Sanders J, Buckner CD, Martin P, Weiden P, Thomas ED: Treatment of acute graft-versus-host disease after allogeneic marrow transplantation: Randomized study comparing corticosteroids and cyclosporine. Am J Med 78:978, 1985
31. Ramsay NKC, Kersey JH, Robison LL, McGlave PB, Woods WG, Krivit W, Kim TH, Goldman AI, Nesbit ME Jr: A randomized study of the prevention of acute graft-versus-host disease. N Engl J Med 306:392, 1982
32. Yau JC, LeMaistre CF, Zagars GK, Williams LA, Meneghetti CM, Luke DR, Dunphy FR, Spinolo JA, Jagannath S, Spitzer G, Zander AR, Dicke KA: Methylprednisone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host disease. Bone Marrow Transplant 5:269, 1990
33. Chao NJ, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long GD, Nadamanee AP, Negrin RS, O'Donnell MR, Parker PM, Smith EP, Snyder DS, Stein AS, Wong RM, Blume KG, Forman SJ: Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. N Engl J Med 329:1225, 1993
34. Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED, and the Seattle Marrow Transplant Team: Antileukemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 304:1529, 1981
35. Sullivan KM, Storb R, Buckner CD, Fefer A, Fisher L, Weiden PL, Witherspoon RP, Appelbaum FR, Banaji M, Hansen J, Martin P, Sanders JE, Singer J, Thomas ED: Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologie neoplasms. N Engl J Med 320:828, 1989
36. Weisdorf DJ, Woods WG, Nesbit ME Jr, Uckun F, Dusenbery K, Kim T, Haake R, Thomas W, Kersey JH, Ramsay NK: Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia: Risk factors and clinical outcome. Br J Haematol 86:62, 1994
37. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb H, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555, 1990
38. Sprent J, Kosaka H, Gao EK: T cell tolerance after bone marrow transplantation in mice. Bone Marrow Transplant 10:5, 1992 (suppl 1)
39. Ochs LA, Miller WJ, Filipovich AH, Haake RJ, McGlave PB, Blazar BR, Ramsay NK, Kersey JH, Weisdorf DJ: Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation. Bone Marrow Transplant 13:455, 1994
40. Vogelsang GB: Acute and chronic graft-versus-host disease. Curr Opin Oncol 5:276, 1993